Etofenamate

Spezifikationen

30544-47-9CAS-Nummer

250-231-8EG-Nummer

2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoateIUPAC-Name

C18H18F3NO4Chemische Formel

369.3 g/molMolekulargewicht

ETOFENAMATE; 30544-47-9; 2-(2-Hydroxyethoxy)ethyl 2-((3-(trifluoromethyl)phenyl)amino)benzoate; Etofenamato; Bay d 1107; Etofenamatum; TVX485; WHR-5020; DTXSID2045448; TVX-485; BAY-D-1107; KZF0XM66JC; Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 2-(2-hydroxyethoxy)ethyl ester; BAYD-1107; 2-(2-hydroxyethoxy)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}benzoate; 2-(2-Hydroxyethoxy)ethyl-N-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilate; Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, 2-(2-hydroxyethoxy)ethyl ester; DTXCID0025448; Traumon; BAYRO; 2-(2-Hydroxyethoxy)ethyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate; RefChem:596843; M02AA06; 2-(2-hydroxyethoxy)-ethyl-N-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilate; 250-231-8; Bayrogel; 2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoate; MFCD00242806; Rheumon; NCGC00016804-01; Rheumon gel; CAS-30544-47-9; Etofenamatum [INN-Latin]; Etofenamato [INN-Spanish]; TVX 485; WHR 5020; EINECS 250-231-8; UNII-KZF0XM66JC; 2-(2-Hydroxyethoxy)ethyl Fufenamate; BRN 2953263; Etofenamate [USAN:INN:BAN]; Etofenamate?; Etofenamate CRS; 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid 2-(2-Hydroxyethoxy)ethyl Ester; Etofenamate (Standard); 2-(2-Hydroxyaethoxy)aethylester der flutenaminsaeure [German]; ETOFENAMATE [MI]; Prestwick0_001014; Prestwick1_001014; Prestwick2_001014; ETOFENAMATE [INN]; ETOFENAMATE [JAN]; Etofenamate (USAN/INN); ETOFENAMATE [USAN]; 2-(2-Hydroxyethoxy)ethyl N-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilate; ETOFENAMATE [MART.]; SCHEMBL25152; ETOFENAMATE [WHO-DD]; 2-(2-Hydroxyaethoxy)aethylester der flutenaminsaeure; SPBio_003038; orb1305323; CHEMBL1451633; CHEBI:94731; EX-A275; ETOFENAMATE [EP MONOGRAPH]; GLXC-04567; HMS1571K09; HMS3713H06; HMS5086L13; EDC83773; Tox21_110618; EBC-07699; HY-17361R; s6742; AKOS026750534; Tox21_110618_1; CCG-220592; CS-0905; DB08984; Etofenamate for peak identification CRS; FE23195; Anthranilic acid, N-(alpha,alpha,alpha-trifluoro-m-tolyl)-, 2-(2-hydroxyethoxy)ethyl ester; NCGC00016804-02; NCGC00016804-03; AC-35208; AS-73948; DA-33632; HY-17361; SY035081; E7857; NS00009824; T2553; D04102; EN300-1692900; F468332; Q414378; SR-01000872640; SR-01000872640-1; BRD-K73541271-001-01-0; BRD-K73541271-001-03-6; Z1248763315; 2-(2-hydroxyethoxy)ethyl 2-[ [3-(trifluoromethyl)phenyl]amino]benzoate; 2-[3-(trifluoromethyl)anilino]benzoic acid 2-(2-hydroxyethoxy)ethyl ester; 2-(2-HYDROXYETHOXY)ETHYL N-(.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)ANTHRANILATESynonyme